CMTM4 Antibodies

Santa Cruz Biotechnology delivers a wide array of CMTM4 monoclonal antibodies for advanced research in cell biology. CMTM4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CMTM4, or CKLF-like MARVEL transmembrane protein 4, plays a significant role in regulating cell proliferation and differentiation. Research has shown CMTM4's involvement in various cellular processes, particularly in cancer progression and immune response modulation. Understanding CMTM4 function continues to reveal new insights about its potential as a therapeutic target in various diseases. Ongoing studies of CMTM4 expression patterns help researchers better understand its role in normal cellular functions and disease states. Current investigations focus on how CMTM4 interacts with other proteins and signaling pathways in different tissue types. Exploring CMTM4's molecular mechanisms provides valuable information for developing targeted therapies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CMTM4 and its therapeutic applications.